SEARCH

SEARCH BY CITATION

References

  • 1
    Pomel C, Barton DPJ, McNeish I, Shepherd J. A statement for extensive primary cytoreductive surgery in advanced ovarian cancer. BJOG 2008;115:80810.
  • 2
    Van der Burg MEL, Van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and treatment of Cancer. N Engl J Med 1995;332:62934.
  • 3
    Rose PG, Nerenstone S, Brady MF, Clarke-Pearson D, Olt G, Rubin SC, et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 2004;351:248997.
  • 4
    Bristow RE, Berek JS. Surgery for ovarian cancer: how to improve survival. Lancet 2006;367:155860.
  • 5
    Naik R, Nordin A, Cross P, Hemming D, De Barros Lopes A, Monaghan JM. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases. Gynecol Oncol 2000;78:1715.
  • 6
    Naik R, Nordin A, Cross P, Hemming D, De Barros Lopes A, Monaghan JM. Complete cytoreduction: Is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease? Gynecol Oncol 2000;78:17680.